KIMIA BIOSCIENCES LIMITED Share Price

KIMIA BIOSCIENCES LIMITED Share Price

BSE: 530313
|
Pharmaceuticals
₹ 31.70
-₹0.83 (-2.55%)
1D
Last updated 24 Jul, 2026, 15:27 IST

KIMIA BIOSCIENCES LIMITED Share Price Today

As of 25 Jul 2026, KIMIA BIOSCIENCES LIMITED share price is ₹31.70. The stock opened at ₹32.53, compared to its previous close of ₹32.53. During today's trading session, KIMIA BIOSCIENCES LIMITED share price moved in the range of ₹31.62 to ₹32.53, with an average price of ₹32.08 for the day. Looking at its last 52-week, the stock has touched a low of ₹23.20 and a high of ₹72.96.

₹31.62
2.55% down today
₹32.53
1D LOW
1D HIGH

KIMIA BIOSCIENCES LIMITED Returns Calculator

Circuit
L
H
₹25.52
₹38.28
52-week
L
H
₹23.20
₹72.96
Mkt Cap Cr
150.93
P/E
20.32
P/B
8.52
ROE
41.95%
D/E
1.96
ROCE
22.81%
Div. Yield
0.00%
EPS(TTM)
1.64
Turnover
2.73
EV/EBITDA
11.83
Net Margin
0.00%
Op. Margin
0.00%
ROA
7.20%
Quick Ratio
0.00
Curr. Ratio
1.29
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Kimia Bioscien. outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Kimia Bioscien. appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,03,472.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories96,204.7030.222.5311.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

KIMIA BIOSCIENCES LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹118.92₹104.88₹128.52₹124.90
Other Income₹1.32₹1.64₹1.21₹0.93
Total Revenue₹120.24₹106.52₹129.73₹125.83
Total Expenses₹106.61₹113.70₹141.07₹130.85
Profit Before Tax₹13.63-₹7.18-₹12.39-₹5.02
Tax₹4.02-₹1.88-₹3.04-₹1.32
Profit After Tax₹9.61-₹5.31-₹9.35-₹3.70
EPS - Basic₹2.03-₹1.12-₹1.98-₹0.78
EPS - Diluted₹2.03-₹1.12-₹1.98-₹0.78

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹13.63-₹7.18-₹12.39-₹5.02
Income before WC changes₹20.46₹0.57-₹4.79₹0.94
Change in Assets-₹13.92₹21.35-₹10.14-₹4.08
Change in Liabilities₹14.72-₹7.41₹8.14₹11.21
Change in WC₹0.80₹13.94-₹2.00₹7.13
Cash flow from Operations₹21.31₹14.53-₹6.77₹8.00
Cash flow from Investing-₹4.70-₹1.49-₹2.80-₹0.71
Cash flow from Financing-₹16.55-₹13.07₹9.54-₹7.67
Total Cash Flow₹0.06-₹0.03-₹0.03-₹0.38
Cash (Start of the year)₹0.15₹0.18₹0.20₹0.59
Cash (End of the year)₹0.21₹0.15₹0.18₹0.20

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹35.92₹38.56₹38.57₹36.42
Current Assets₹75.29₹61.41₹82.75₹73.07
Total Assets₹111.21₹99.97₹121.32₹109.49
Current Liabilities₹81.83₹69.44₹76.40₹61.80
Net Current Asset-₹6.53-₹8.03₹6.35₹11.27
Non-Current Liabilities₹19.42₹30.20₹39.46₹32.80
Equity Capital₹9.97₹0.33₹5.46₹14.89
Total Equity & Liabilities₹111.21₹99.97₹121.32₹109.49
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
0
Neutral
5
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
45
Neutral
ATR (14)
1.54
Neutral
STOCH(9,6)
8.31
Bullish
STOCH RSI (14)
40.19
Neutral
ADX(9)
15.71
Bullish
UO(9)
38.51
Neutral
ROC(12)
3.98
Bullish
WillR(14)
-61.92
Neutral
Period
Simple value
Exponential vaue
5D
33.21
32.78
10D
33.11
32.79
20D
32.28
32.7
50D
33.43
33.03
100D
32.99
33.03

About KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED Share Price
ISIN
INE285U01025
Sector Market Cap
₹ 150.93 Cr

Kimia Biosciences Limited is an India-based company, which is engaged in the manufacturing of bulk drugs addressing various high-potential therapeutic segments. The Company provides its products under various categories: Commercial Active Pharmaceutical Ingredients (APIs), and Commercial KSMs, Intermediates and Reagents. The Company's Commercial-APIs products include Acotiamide Hydrochloride Hydrate, Azelnidipine, Benfotiamine, Benidipine Hydrochloride, Citicoline Sodium, Gliclazide, Dapagliflozin Propanediol Monohydrate, Levosulpiride, Luliconazole, Oxaceprol, Prucalopride Succinate, Teneligliptin Hydrobromide Hydrate, Vildagliptin, Fimasartan Trihydrate Potassium, Obeticholic Acid, Ursodeoxycholic Acid and others. Its Commercial KSMs, Intermediates and Reagents products include Ethyl-2-Amino 1,3-Thiazole 4-Carboxylate; 2,4,5-Trimethoxy Benzoic Acid; Ethyl 2-(2,4,5-trimethoxybenzamido)-1,3-thiazole-4-carboxylate; Choline phosphate chloride calcium, and others.

KIMIA BIOSCIENCES LIMITED Financial Highlights

  • Revenue: KIMIA BIOSCIENCES LIMITED reported revenue of ₹116.50 crore in FY26 vs ₹120.24 crore in FY25. It showed a decrease of 3.11% on a yearly basis.
  • Operating Profit: KIMIA BIOSCIENCES LIMITED reported an operating profit of ₹8.46 crore in FY26 vs ₹13.63 crore in FY25. It showed a decrease of 37.93% on a year-on-year basis.
  • Net Profit: KIMIA BIOSCIENCES LIMITED reported a net profit of ₹7.43 crore in FY26 vs ₹9.61 crore in FY25. It showed a decrease of 22.68% on a yearly basis.

KIMIA BIOSCIENCES LIMITED Quarterly Result Highlights

  • KIMIA BIOSCIENCES LIMITED reported revenue of ₹28.21 crore in Mar 2026, compared with ₹30.20 crore in Dec 2025, representing a decrease of 6.59% on a quarter-on-quarter (QoQ) basis.
  • KIMIA BIOSCIENCES LIMITED reported an operating profit of ₹1.76 crore in Mar 2026, compared with ₹5.05 crore in Dec 2025, representing a decrease of 65.15% on a quarter-on-quarter (QoQ) basis.
  • KIMIA BIOSCIENCES LIMITED reported a profit of ₹0.37 crore in Mar 2026, compared with ₹5.44 crore in Dec 2025, reflecting a decrease of 93.20% on a QoQ basis.
  • The earnings per share (EPS) of KIMIA BIOSCIENCES LIMITED stood at ₹2.03 during Mar 2026.
Know more
Promoters
74.94%
FII
0.00%
Other DII
0.00%
Retail and other
24.68%
Mutual funds
0.38%
Foreign institutions - FII
Compare against other stocks
KIMIA BIOSCIENCES LIMITED Share Price
KIMIA BIOSCIENCES LIMITED
Pharmaceuticals
Add Stock
Add Another

FAQs on KIMIA BIOSCIENCES LIMITED Share Price